​

Bolt Biotherapeutics (BOLT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Bolt Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$7.69M

Latest Revenue (Q)

$1.22M

Bolt Biotherapeutics Revenue by Period

Bolt Biotherapeutics Revenue by Year

DateRevenueChange
2024-12-31$7.69M-2.36%
2023-12-31$7.88M37.48%
2022-12-31$5.73M354.68%
2021-12-31$1.26M445.45%
2020-12-31$231.00K7.44%
2019-12-31$215.00K100.00%
2018-12-31--

Bolt Biotherapeutics generated $7.69M in revenue during NA 2024, up -2.36% compared to the previous quarter, and up 3576.74% compared to the same period a year ago.

Bolt Biotherapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$1.22M100.00%
2024-12-31--100.00%
2024-09-30$1.14M-10.51%
2024-06-30$1.27M-75.82%
2024-03-31$5.27M152.47%
2023-12-31$2.09M-17.37%
2023-09-30$2.53M76.41%
2023-06-30$1.43M-21.52%
2023-03-31$1.83M29.41%
2022-12-31$1.41M-33.19%
2022-09-30$2.11M51.62%
2022-06-30$1.39M71.34%
2022-03-31$813.00K60.04%
2021-12-31$508.00K-32.45%
2021-09-30$752.00K100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30--100.00%
2020-06-30$67.00K-59.15%
2020-03-31$164.00K152.31%
2019-12-31$65.00K-46.28%
2019-09-30$121.00K734.48%
2019-06-30$14.50K-
2019-03-31$14.50K-

Bolt Biotherapeutics generated $1.22M in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up 58.50% compared to the same period a year ago.

Bolt Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRKRMarker Therapeutics$6.59T$349.10K
BOLTBolt Biotherapeutics$7.69M$1.22M
EVGNEvogene$5.64M$4.19M
HCWBHCW Biologics$2.57M$6.55K
LYRALyra Therapeutics$1.53M$183.00K
ABPAbpro$122.00K-
DWTXDogwood Therapeutics--
CINGCingulate--
KALAKALA BIO--
RNAZTransCode Therapeutics--
INABIN8bio--

BOLT Revenue FAQ

What is Bolt Biotherapeutics’s yearly revenue?

Bolt Biotherapeutics's yearly revenue for 2024 was $7.69M, representing a decrease of -2.36% compared to 2023. The company's yearly revenue for 2023 was $7.88M, representing an increase of 37.48% compared to 2022. BOLT's yearly revenue for 2022 was $5.73M, representing an increase of 354.68% compared to 2021.

What is Bolt Biotherapeutics’s quarterly revenue?

Bolt Biotherapeutics's quarterly revenue for Q1 2025 was $1.22M, a 100.00% increase from the previous quarter (Q4 2024), and a -76.83% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $0, a -100.00% decrease from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). BOLT's quarterly revenue for Q3 2024 was $1.14M, a -10.51% decrease from the previous quarter (Q2 2024), and a -54.87% decrease year-over-year (Q3 2023).

What is Bolt Biotherapeutics’s revenue growth rate?

Bolt Biotherapeutics's revenue growth rate for the last 3 years (2022-2024) was 34.23%, and for the last 5 years (2020-2024) was 3229.00%.